Factors associated with excessive bleeding in cardiopulmonary bypass patients: A nested case-control study

Journal of Cardiothoracic Surgery

Volumn 2, Issue 1, 2007, Pages

  Jimenez Rivera, Juan J ^a   Iribarren, Jose L ^a   Raya, Jose M ^a   Nassar, Ibrahim ^a   Lorente, Leonardo ^a   Perez, Rosalia ^a   Brouard, Maitane ^a   Lorenzo, Jose M ^a   Garrido, Pilar ^a   Barrios, Ysamar ^a   Diaz, Maribel ^a   Alarco, Blas ^a   Martinez, Rafael ^a   Mora, Maria L ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PHYSIOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROBABILITY; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 34248330831     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-2-17     Document Type: Article

References (27)

1. Hess PJ Jr. Systemic inflammatory response to coronary artery bypass graft surgery Am J Health Syst Pharm 2005 62 S6-S9 10.2146/ajhp050302 16227195
2. Hertfelder HJ Bos M Weber D Winkler K Hanfland P Preusse CJ Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting Semin Thromb Hemost 2005 31 426-440 10.1055/ s-2005-916678 16149021
3. Moulton MJ Creswell LL Mackey ME Cox JL Rosenbloom M Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations J Thorac Cardiovasc Surg 1996 111 1037-1046 10.1016/ S0022-5223(96)70380-X 8622301
4. Vaughan DE Angiotensin, fibrinolysis, and vascular homeostasis Am J Cardiol 2001 %19;87 18C-24C 10.1016/S0002-9149(01)01509-0
5. Welsby IJ Podgoreanu MV Phillips-Bute B Mathew JP Smith PK Newman MF Schwinn DA Stafford-Smith M Genetic factors contribute to bleeding after cardiac surgery J Thromb Haemost 2005 3 1206-1212 10.1111/ j.1538-7836.2005.01337.x 15892865
6. Donahue BS Gailani D Higgins MS Drinkwater DC George AL Jr. Factor V Leiden protects against blood loss and transfusion after cardiac surgery Circulation 2003 107 1003-1008 10.1161/01.CIR.0000051864.28048.01 12600914
7. Carroll RC Chavez JJ Snider CC Meyer DS Muenchen RA Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery J Lab Clin Med 2006 147 197-204 10.1016/j.lab.2005.12.007 16581348
8. Belisle S Hardy JF Hemorrhage and the use of blood products after adult cardiac operations: Myths and realities Ann Thorac Surg 1996 62 1908-1917 10.1016/S0003-4975(96)00944-7 8957433
9. Woodman RC Harker LA Bleeding complications associated with cardiopulmonary bypass Blood 1990 76 1680-1697 2224118
10. Dawson S Hamsten A Wiman B Henney A Humphries S Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity Arterioscler Thromb 1991 11 183-190 1670989
11. Engles L Review and application of serine protease inhibition in coronary artery bypass graft surgery Am J Health Syst Pharm 2005 62 S9-14 10.2146/ajhp050300 16227196
12. Nuttall GA Henderson N Quinn M Blair C Summers L Williams BA Oliver WC Santrach PJ Excessive bleeding and transfusion in a prior cardiac surgery is associated with excessive bleeding and transfusion in the next surgery Anesth Analg 2006 102 1012-1017 10.1213/ 01.ane.0000198563.28246.00 16551890
13. Karthik S Grayson AD McCarron EE Pullan DM Desmond MJ Reexploration for bleeding after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay Ann Thorac Surg 2004 78 527-534 10.1016/ j.athoracsur.2004.02.088 15276512
14. Gomez-Ambrosi J Salvador J Silva C Pastor C Rotellar F Gil MJ Cienfuegos JA Fruhbeck G Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin Thromb Haemost 2006 95 991-996 16732378
15. Nieuwdorp M Stroes ES Meijers JC Buller H Hypercoagulability in the metabolic syndrome Curr Opin Pharmacol 2005 5 155-159 10.1016/ j.coph.2004.10.003 15780824
16. Hoekstra T Geleijnse JM Schouten EG Kluft C Plasminogen activator inhibitor-type 1: Its plasma determinants and relation with cardiovascular risk Thromb Haemost 2004 91 861-872 15116245
17. Sartori MT Vettor R De PG De M V Saggiorato G Della MP Patrassi GM Lombardi AM Fabris R Girolami A Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: Influence of fat distribution and insulin-resistance Thromb Haemost 2001 86 1161-1169 11816701
18. De M V De PG Vettor R Marino R Sciaraffia M Pagano C Scaraggi FA Di LL Giorgino R Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women Metabolism 1999 48 960-964 10.1016/S0026-0495(99)90190-7 10459558
19. Mantzoros CS The role of leptin in human obesity and disease: A review of current evidence Ann Intern Med 1999 %20;130 671-680
20. Skurk T van H V Lee YM Wirth A Hauner H Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients Horm Metab Res 2002 34 659-663 10.1055/ s-2002-38253 12660878
21. Parr KG Patel MA Dekker R Levin R Glynn R Avorn J Morse DS Multivariate predictors of blood product use in cardiac surgery J Cardiothorac Vasc Anesth 2003 17 176-181 10.1053/jcan.2003.44 12698398
22. Despotis GJ Avidan MS Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 2001 72 S1821-S1831 10.1016/S0003-4975(01)03211-8 11722116
23. Reinartz J Hansch GM Kramer MD Complement component C7 is a plasminogen-binding protein J Immunol 1995 154 844-850 7814888
24. Chen JC Rollins SA Shernan SK Boyce S Allen K Wallace A Malloy KJ Eng JS Colman RW Fitch JC Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiac surgery J Card Surg 2005 20 35-41 10.1111/ j.0886-0440.2005.200370.x 15673408
25. Carrier M Menasche P Levy JH Newman MF Taylor KM Haverich A Chen JC Shernan SK Van de WF van der LM Todaro TG Adams PX Verrier ED Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery J Thorac Cardiovasc Surg 2006 131 352-356 10.1016/ j.jtcvs.2005.10.011 16434264
26. Kirklin JK Chenoweth DE Naftel DC Blackstone EH Kirklin JW Bitran DD Curd JG Reves JG Samuelson PN Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state Ann Thorac Surg 1986 41 193-199 3947172
27. Kuepper F Dangas G Mueller-Chorus A Kulka PM Zenz M Wiebalck A Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy Blood Coagul Fibrinolysis 2003 14 147-153 10.1097/00001721-200302000-00005 12632024